Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Highlights Advanced Drug Manufacturing Approaches In Budget Plan

Feb 13 2018

• By Derrick Gingery

FDAEntrance_1200x675

Related Content

Will Continuous Manufacturing Mean Continuous Generic Delay? FDA Hears AAM's Warning

Dec 04 2017

FDA Talks Up Continuous Manufacturing, Offers Assistance

Jul 29 2014

FDA Commissioner Outlines Priorities For Tightening Oversight Of Drug Compounding Facilities

Jan 19 2018

Opioid, NME, And Generic Drugs Changes Plotted In US FDA's 2018 Policy Roadmap

Jan 25 2018

FDA Should Drop Ban On Office Compounding, US House Members Say

Jan 31 2018

At Cross-Purposes? How Trump Budget's Part D Gap Discount Policy Aligns With New Law

Feb 12 2018

Trump's Budget Surprise: FDA Gains 13% Increase

Feb 12 2018

FDA Making A Generic Case For Continuous Manufacturing

May 02 2016

Drug Compounding Can't Be Justified By Price, FDA Says

Jul 10 2016

Additional Topics

United States FDA Manufacturing Regulation Legislation BioPharmaceutical

More from US FDA

More from Agency Leadership

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window